Experience with ABO-Incompatible Kidney Transplantation

  • Yi WangEmail author
  • Hongtao Jiang
  • Luogen Liu


Since the 1990s, more and more medical researchers all over the world have been studying ABO-incompatible kidney transplantation (ABOi-KT) and already made tremendous progress. The first ABOi-KT in mainland China was carried out by Professor Wang Yi in 2006. The whole treatments, including the strict selection of donors and recipients, the effective removal of antibodies, the perioperative managements, and the monitoring for rejection, have been optimized by Wang Yi and his team. This chapter will focus on the experience of ABOi-KT success as well as the comparative overview of ABOi-KT in different countries. All of the successful ABOi-KT experience not only provides other ABOi organ transplants with the specific methods to overcome the primary obstacle of ABO blood type incompatibility but also helps to relieve the organ shortage efficiently.


ABOi-KT transplantation Transplantation indications Plasma desensitization scheme Postoperative management 


  1. 1.
    Shishido S, Hyodo YY, Aoki Y, et al. Outcomes of pediatric abo-incompatible kidney transplantations are equivalent to abo-compatible controls. Transplant Proc. 2012;44:214–6.CrossRefGoogle Scholar
  2. 2.
    Warren DS, Montgomery RA. Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange. Immunol Res. 2010;47:257–64.CrossRefGoogle Scholar
  3. 3.
    Beimler J, Zeier M. Abo-incompatible transplantation—a safe way to perform renal transplantation? Nephrol Dial Transplant. 2007;22:25–7.CrossRefGoogle Scholar
  4. 4.
    Kobayashi T, Liu D, Ogawa H, et al. Removal of blood group a/b antigen in organs by ex vivo and in vivo administration of endo-beta-galactosidase (abase) for abo-incompatible transplantation. Transpl Immunol. 2009;20:132–8.CrossRefGoogle Scholar
  5. 5.
    Montgomery JR, Berger JC, Warren DS, et al. Outcomes of abo-incompatible kidney transplantation in the United States. Transplantation. 2012;93:603–9.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Toki D, Ishida H, Setoguchi K, et al. Acute antibody-mediated rejection in living abo-incompatible kidney transplantation: long-term impact and risk factors. Am J Transplant. 2009;9:567–77.CrossRefGoogle Scholar
  7. 7.
    Tanabe T, Ishida H, Horita S, et al. Decrease of blood type antigenicity over the long-term after abo-incompatible kidney transplantation. Transpl Immunol. 2011;25:1–6.CrossRefGoogle Scholar
  8. 8.
    Rienstra H, Boersema M, Onuta G, et al. Donor and recipient origin of mesenchymal and endothelial cells in chronic renal allograft remodeling. Am J Transplant. 2009;9:463–72.CrossRefGoogle Scholar
  9. 9.
    Kwon O, Miller S, Li N, et al. Bone marrow-derived endothelial progenitor cells and endothelial cells may contribute to endothelial repair in the kidney immediately after ischemia-reperfusion. J Histochem Cytochem. 2010;58:687–94.CrossRefGoogle Scholar
  10. 10.
    Taylor RP, Lindorfer MA. Impact of low-dose rituximab on splenic B cells: evidence for the shaving reaction. Transpl Int. 2010;23:116–7.CrossRefGoogle Scholar
  11. 11.
    Li Y, Williams ME, Cousar JB, et al. Rituximab-CD20 complexes are shaved from Z138 mantle cell lymphoma cells in intravenous and subcutaneous SCID mouse models. J Immunol. 2007;179:4263–71.CrossRefGoogle Scholar
  12. 12.
    Tasaki M, Nakajima T, Imai N, et al. Detection of allogeneic blood group a and b enzyme activities in patients with abo incompatible kidney transplantation. Glycobiology. 2010;20:1251–8.CrossRefGoogle Scholar
  13. 13.
    Genberg H, Kumlien G, Wennberg L, et al. Isoagglutinin adsorption in abo-incompatible transplantation. Transfus Apher Sci. 2010;43:231–5.CrossRefGoogle Scholar
  14. 14.
    Silvestre C, Furian L, Marson P, et al. Desensitization with plasmapheresis and anti-CD20 for abo incompatible kidney transplantation from living donor: experience of a single center in Italy. Transplant Proc. 2014;46:2209–13.CrossRefGoogle Scholar
  15. 15.
    Takahashi K, Saito K. Abo-incompatible kidney transplantation. Transplant Rev (Orlando). 2013;27:1–8.CrossRefGoogle Scholar
  16. 16.
    Tasaki M, Saito K, Nakagawa Y, et al. 20-year analysis of kidney transplantation: a single center in Japan. Transplant Proc. 2014;46:437–41.CrossRefGoogle Scholar
  17. 17.
    Oettl T, Halter J, Bachmann A, et al. Abo blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies. Nephrol Dial Transplant. 2009;24:298–303.CrossRefGoogle Scholar
  18. 18.
    Zschiedrich S, Kramer-Zucker A, Janigen B, et al. An update on abo-incompatible kidney transplantation. Transpl Int. 2015;28:387–97.CrossRefGoogle Scholar
  19. 19.
    Yi Wang, Zhi Gang Luo, Peigen Gui, et al. A case report of living relative ABO incompatible kidney transplantation which had preserved the spleen of recipients. Chinese J Organ Transplant. 2007;28:694–5.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.The Second Affiliated Hospital of Hainan Medical UniversityHaikou CityChina
  2. 2.The Second Affiliated HospitalUniversity of South ChinaHengyang CityChina

Personalised recommendations